Abstract
The global tuberculosis epidemic is being fuelled by dual infection with human immunodeficiency virus type I. Short-course chemotherapy is effective but usually fails for operational reasons. A community-based treatment programme of twice-weekly fully-supervised treatment is described in which 89% of surviving patients completed treatment under programme conditions. Half the patients were successfully supervised by non-health workers. New approaches are needed to combat the global tuberculosis epidemic.
Original language | English |
---|---|
Pages (from-to) | 647-648 |
Number of pages | 2 |
Journal | The Lancet |
Volume | 343 |
Issue number | 8898 |
DOIs | |
Publication status | Published - 12 Mar 1994 |
Externally published | Yes |